Dme (India) Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 8.60 Cr
as on 24-10-2024
- Company Age 31 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.00 M
as on 24-10-2024
- Revenue 2.60%
(FY 2023)
- Profit 71.74%
(FY 2023)
- Ebitda 21.26%
(FY 2023)
- Net Worth 8.09%
(FY 2023)
- Total Assets 10.09%
(FY 2023)
About Dme (India)
The Corporate was formerly known as D-M-E Company (India) Private Limited. The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 8.60 Cr.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ryan Kean and Sreedharan Jayakaran serve as directors at the Company.
- CIN/LLPIN
U74999KA1993PLC046003
- Company No.
046003
- Incorporation Date
09 Mar 1993
- Date of AGM
24 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dme (India) Private Limited offer?
Dme (India) Private Limited offers a wide range of products and services, including Industrial & Engineering Goods, Industrial Nozzles, Stamping Tools & Stamping Machine, Round Stamp & Pre Ink Stamp, Door Lock, Electronic Lock & Latches, Door Lock, Cleaning Liquids & Wipes, Cleaning Chemicals, Chemical Reactors and Process Tanks, Pressure Vessels.
Who are the key members and board of directors at Dme (India)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreedharan Jayakaran  | Managing Director | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ryan Kean  | Director | 12-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Dme (India).
Dme (India) Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.6% increase. The company also saw a substantial improvement in profitability, with a 71.74% increase in profit. The company's net worth moved up by a moderate rise of 8.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dme (India)?
In 2023, Dme (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Yes Bank Limited Creation Date: 30 Mar 2011 | ₹1.00 M | Satisfied |
How Many Employees Work at Dme (India)?
Dme (India) has a workforce of 98 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dme (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dme (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
